SCHEMBL18157318

SCHEMBL18157318

Cc1ccc(Nc2ccc(/C=C/C=C/c3ccc(N(c4ccc(C)cc4)c4ccc(C)cc4)cc3)c3ccccc23)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS2 P35354 1/20 0.41
APP P05067 3/20 0.38
KDM1A O60341 2/20 0.37
GAA P10253 4/20 0.36
MAPT P10636 3/20 0.36
TDP1 Q9NUW8 2/20 0.36
NPC1 O15118 2/20 0.35
RAB9A P51151 2/20 0.35
HPGD P15428 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
KDR P35968 1/20 0.34
MEN1 O00255 2/20 0.34
KMT2A Q03164 2/20 0.34
KDM4E B2RXH2 1/20 0.34
GLA P06280 1/20 0.34
RECQL P46063 1/20 0.34
MAPK1 P28482 2/20 0.34
POLB P06746 1/20 0.34
NPY5R Q15761 1/20 0.33
ACP1 P24666 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18159875 0.92 ACP1 (0.44) PTGS2KDM1AGAAMAPTTDP1
SCHEMBL18157328 0.85 PTGS2 (0.41) PTGS2APPKDM1AGAAMAPT
SCHEMBL18157317 0.79 APP (0.40) APPMAPTNPC1RAB9AHPGD
SCHEMBL18159834 0.78 RELA (0.42) PTGS2KDM1AGAAMAPTTDP1
SCHEMBL20109433 0.78 APP (0.45) PTGS2APPMAPTTDP1NPC1
SCHEMBL13900007 0.78 APP (0.55) APPMAPTNPC1RAB9AHPGD
SCHEMBL22502951 0.78 FGF23 (0.47) APPMAPTHPGDALDH1A1
SCHEMBL22502947 0.75 TRPM8 (0.46) APPMAPTTDP1HPGDL3MBTL1
SCHEMBL14727250 0.74 MAOB (0.54) APPGAAMAPTTDP1RAB9A
SCHEMBL2622626 0.74 MAOB (0.54) APPGAAMAPTTDP1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9663447-B2 Asymmetric butadiene-based charge transport compound, electrophotographic photoreceptor containing same, and image forming apparatus S-PRINTING SOLUTION CO., LTD. (KR) 2017-05-30 US disclosed
US-9663447-B2 Asymmetric butadiene-based charge transport compound, electrophotographic photoreceptor containing same, and image forming apparatus S-PRINTING SOLUTION CO., LTD. (KR) 2017-05-30 US disclosed
US-20160304437-A1 ASYMMETRIC BUTADIENE-BASED CHARGE TRANSPORT COMPOUND, ELECTROPHOTOGRAPHIC PHOTORECEPTOR CONTAINING SAME, AND IMAGE FORMING APPARATUS SAMSUNG ELECTRONICS CO., LTD. (KR) 2016-10-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160304437-A1 ASYMMETRIC BUTADIENE-BASED CHARGE TRANSPORT COMPOUND, ELECTROPHOTOGRAPHIC PHOTORECEPTOR CONTAINING SAME, AND IMAGE FORMING APPARATUS ALDH1A2, USE1, SLC9A1 PTGS2 2881/4885APP 2156/4885KDM1A 2294/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.